Recognized standard
F2260-18
FDA recognition 15-66 · ASTM · Tissue Engineering
Key facts
| Recognition number | 15-66 |
|---|---|
| Designation | F2260-18 |
| Title | Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (1HNMR) Spectroscopy |
| Standards developer | ASTM International |
| Specialty area | Tissue Engineering |
| Date of entry | Jun 7, 2021 |
| Scope (excerpt) | 1.1 This test method covers the determination of the degree of deacetylation in chitosan and chitosan salts intended for use in biomedical and pharmaceutical applications as well as in Tissue Engineered Medical Products (TEMPs) by high-resolution proton NMR (1H NMR). A guide for the characterization… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: